By Michael Erman (Reuters) -Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine...
Read moreBy Edward McAllister and Cooper Inveen DAKAR/ACCRA (Reuters) - It's noisy inside the Mamprobi clinic in Accra as kids clamber...
Read moreBy Tim Cocks JOHANNESBURG (Reuters) - Africa's first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated...
Read moreTOKYO (Reuters) - An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes...
Read moreBy Mrinalika Roy (Reuters) -A third dose of the COVID-19 vaccine from Pfizer Inc and BioNTech produced significant protection against...
Read moreBANGKOK (Reuters) - A prominent Thai politician faces up to 20 years in prison following his indictment on Monday for...
Read moreBy Kanishka Singh WASHINGTON (Reuters) - A Chinese national has been sentenced to 29 months in prison after pleading guilty...
Read more(Reuters) - A fourth dose of the Pfizer/BioNTech vaccine lowered rates of COVID-19 among the elderly but the protection against...
Read moreBy Ludwig Burger and Emilio Parodi (Reuters) - As governments prepare to live with COVID-19, some are questioning how much...
Read moreBy Ludwig Burger (Reuters) - The European Union is setting up centres on its borders to Ukraine to receive and...
Read more(Reuters) - Russians have rushed to stock up on anti-depressants, sleeping pills and contraceptives among other products since the conflict...
Read moreBERLIN (Reuters) - Germany's health minister on Friday urged people over age 60 with risk factors such as high blood...
Read more(Reuters) - Canada's ruling Liberal Party and the opposition New Democratic Party (NDP) have reached a rare agreement that aims...
Read more(Reuters) - Europe's drug regulator said on Tuesday it had begun reviewing AstraZeneca Plc's application for antibody-based COVID-19 therapy, a...
Read moreSHANGHAI (Reuters) - China has granted approval to five COVID-19 antigen kits made by local companies to be used for...
Read moreBy Manas Mishra (Reuters) - The Russian invasion of Ukraine has left drugmakers scrambling to find ways for patients enrolled...
Read moreJOHANNESBURG (Reuters) - About 100,000 doses of Pfizer's COVID-19 vaccine are at risk of being destroyed by the end of...
Read moreBy Michael Erman (Reuters) - Pfizer Inc is expected to provide around 10 million courses of its highly effective COVID-19...
Read moreBy John Revill ZURICH (Reuters) - Swiss voters rejected a proposal by animal rights activists to make Switzerland the first...
Read moreBy John Revill ZURICH (Reuters) - Switzerland votes on Sunday whether to become the first country to completely ban medical...
Read more